Intra-hepatic cholangiocarcinoma - Frequency and demographic patterns: Thirty-year data from the M.D. Anderson Cancer Center

Journal of Cancer Research and Clinical Oncology

Volumn 137, Issue 7, 2011, Pages 1071-1078

  Singal, Ashwani K ^a,b   Vauthey, Jean Nicolas ^a   Grady, James J ^b   Stroehlein, John R ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Cholangiocarcinoma; Demographics; Epidemiology; Intra hepatic cholangiocarcinoma

Indexed keywords

ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER REGISTRY; CAUCASIAN; CONTROLLED STUDY; DEMOGRAPHY; ETHNICITY; EXTRAHEPATIC CHOLANGIOCARCINOMA; FEMALE; HISPANIC; HUMAN; INTRAHEPATIC CHOLANGIOCARCINOMA; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; SEX DIFFERENCE; TREND STUDY;

AGE DISTRIBUTION; AGED; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; ETHNIC GROUPS; FEMALE; HEPATECTOMY; HUMANS; IMMUNOENZYME TECHNIQUES; INCIDENCE; MALE; MIDDLE AGED; PROGNOSIS; SEX DISTRIBUTION; SURVIVAL RATE; TEXAS; TIME FACTORS;

EID: 79959687181     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-010-0971-z     Document Type: Article

References (25)

1. Altaee MY, Johnson PJ, Farrant JM, Williams R (1991) Etiologic and clinical characteristics of peripheral and hilar cholangiocarcinoma. Cancer 68(9):2051-2055. Available from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi? cmd=Retrieve&db=PubMed&dopt=Citation&list-uids=1717133
2. Alvaro D, Crocetti E, Ferretti S, Bragazzi MC, Capocaccia R (2010) Descriptive epidemiology of cholangiocarcinoma in Italy. Dig Liver Dis 42(7):490-495. Available from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd= Retrieve&db=PubMed&dopt=Citation&list-uids=20022823
3. Chapman R, Fevery J, Kalloo A, Nagorney DM, Boberg KM, Shneider B et al. (2010) Diagnosis and management of primary sclerosing cholangitis. Hepatology 51(2):660-78. Available from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd= Retrieve&db=PubMed&dopt=Citation&list-uids=20101749
4. Donato F, Gelatti U, Tagger A, Favret M, Ribero ML, Callea F et al. (2001) Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy. Cancer Causes Control 12(10):959-64. Available from http://www.ncbi.nlm.nih.gov/entrez/ query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list-uids=11808716 (Pubitemid 34048878)
5. El-Serag HB, Mason AC (1999) Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 340(10):745-750. Available from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list-uids=10072408 (Pubitemid 29114292)
6. El-Serag HB, Engels EA, Landgren O, Chiao E, Henderson L, Amaratunge HC et al. (2009) Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: a population-based study of U.S. veterans. Hepatology 49(1):116-123. Available from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd= Retrieve&db=PubMed&dopt=Citation&list-uids=19085911
7. Endo I, Gonen M, Yopp AC, Dalal KM, Zhou Q, Klimstra D et al. (2008) Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Ann Surg 248(1):84-96. Available from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list-uids=18580211
8. Jepsen P, Vilstrup H, Tarone RE, Friis S, Sorensen HT (2007) Incidence rates of intra- and extrahepatic cholangiocarcinomas in Denmark from 1978 through 2002. J Natl Cancer Inst 99(11):895-897. Available from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list-uids=17551150 (Pubitemid 47073512)
9. Khan SA, Taylor-Robinson SD, Toledano MB, Beck A, Elliott P, Thomas HC (2002) Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J Hepatol 37(6):806-813. Available from http://www.ncbi.nlm. nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt= Citation&list-uids=12445422 (Pubitemid 35404220)
10. Khan SA, Miras A, Pelling M, Taylor-Robinson SD (2007) Cholangiocarcinoma and its management. Gut 56(12):1755-1756. Available from http://www.ncbi.nlm. nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt= Citation&list-uids=17998326 (Pubitemid 350206304)
11. Khan SA, Toledano MB, Taylor-Robinson SD (2008) Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma. HPB (Oxford) 10(2):77-82. Available from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd= Retrieve&db=PubMed&dopt=Citation&list-uids=18773060 (Pubitemid 351934989)
12. Kobayashi M, Ikeda K, Saitoh S, Suzuki F, Tsubota A, Suzuki Y et al. (2000) Incidence of primary cholangiocellular carcinoma of the liver in japanese patients with hepatitis C virus-related cirrhosis. Cancer 88(11):2471-2477. Available from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd= Retrieve&db=PubMed&dopt=Citation&list-uids=10861422 (Pubitemid 30331952)
13. McGlynn KA, Tarone RE, El-Serag HB (2006) A comparison of trends in the incidence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in the United States. Cancer Epidemiol Biomarkers Prev 15(6):1198-1203. Available from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list-uids=16775181
14. Oh SW, Yoon YS, Shin SA (2005) Effects of excess weight on cancer incidences depending on cancer sites and histologic findings among men: Korea National Health Insurance Corporation Study. J Clin Oncol 23(21):4742-4754. Available from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd= Retrieve&db=PubMed&dopt=Citation&list-uids=16034050 (Pubitemid 46224078)
15. Patel T (2002) Worldwide trends in mortality from biliary tract malignancies. BMC Cancer 2:10. Available from http://www.ncbi.nlm.nih.gov/ entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list-uids= 11991810
16. Shaib Y, El-Serag HB (2004) The epidemiology of cholangiocarcinoma. Semin Liver Dis 24(2):115-125. Available from http://www.ncbi.nlm.nih.gov/entrez/ query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list-uids=15192785 (Pubitemid 38738341)
17. Shaib YH, Davila JA, McGlynn K, El-Serag HB (2004) Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J Hepatol 40(3):472-477. Available from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi? cmd=Retrieve&db=PubMed&dopt=Citation&list-uids=15123362 (Pubitemid 38230849)
18. Shaib YH, El-Serag HB, Davila JA, Morgan R, McGlynn KA (2005) Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology 128(3):620-626. Available from http://www.ncbi.nlm.nih. gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list- uids=15765398 (Pubitemid 40585364)
19. Shaib YH, El-Serag HB, Nooka AK, Thomas M, Brown TD, Patt YZ et al. (2007) Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study. Am J Gastroenterol 102(5):1016-1021. Available from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd= Retrieve&db=PubMed&dopt=Citation&list-uids=17324130 (Pubitemid 46698225)
20. Taylor-Robinson SD, Toledano MB, Arora S, Keegan TJ, Hargreaves S, Beck A et al. (2001) Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998. Gut 48(6):816-820. Available from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list-uids=11358902
21. Welzel TM, McGlynn KA, Hsing AW, O'Brien TR, Pfeiffer RM (2006) Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States. J Natl Cancer Inst 98(12):873-875. Available from http://www.ncbi.nlm.nih.gov/entrez/ query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list-uids=16788161 (Pubitemid 43923444)
22. Welzel TM, Mellemkjaer L, Gloria G, Sakoda LC, Hsing AW, El Ghormli L et al. (2007) Risk factors for intrahepatic cholangiocarcinoma in a low-risk population: a nationwide case-control study. Int J Cancer 120(3):638-641. Available from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd= Retrieve&db=PubMed&dopt=Citation&list-uids=17109384 (Pubitemid 46001359)
23. Welzel TM, Graubard BI, El-Serag HB, Shaib YH, Hsing AW, Davila JA et al. (2007) Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study. Clin Gastroenterol Hepatol 5(10):1221-1228. Available from http://www.ncbi.nlm.nih.gov/entrez/ query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list-uids=17689296 (Pubitemid 47496233)
24. West J, Wood H, Logan RF, Quinn M, Aithal GP (2006) Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971-2001. Br J Cancer 94(11):1751-1758. Available from http://www.ncbi.nlm.nih. gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list- uids=16736026 (Pubitemid 43924943)
25. Wood R, Brewster DH, Fraser LA, Brown H, Hayes PC, Garden OJ (2003) Do increases in mortality from intra-hepatic cholangiocarcinoma reflectagenuineincreaseinrisk?Insightsfromcancerregistrydatain Scotland. Eur J Cancer 39(14):2087-2092. Available from http://www.ncbi.nlm.nih.gov/entrez/ query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list-uids=12957464 (Pubitemid 37297766)